A family office based in the US Southeast invests in healthcare in addition to other sectors. The firm makes equity investments ranging from early stage to full on commercialization, but also provides debt and convertible loan financing. The firm generally looks for USA-based opportunities but may consider deals outside of the USA and has a track record of working with companies globally. The firm seeks to make approximately 6-10 investments per year.
In the life sciences, the family office has a strong interest in medical device and diagnostic companies. The firm considers healthcare IT opportunities to a lesser degree, and will not consider biopharma companies for the most part. The family office is open to devices of all FDA regulatory pathways including 510k and PMA. The family office is very opportunistic regarding the company’s stage of development and will consider products that are both on- and off-market.
The family office is looking for privately held companies backed by an experienced management team. Companies should have a strong exit strategy, including having a direct line of contact with strategic or financial buyers. The firm is open to both leading and co-investing in a financing round.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Leave a Reply